Seminar: Accelerating Clinical Development from First-In-Human to Proof-Of-Concept

February / March 2017

This seminar will describe how Quotient Clinical’s unique Enabled-First-In-Human® programs significantly reduce the time and cost required to transition to Proof-Of-Concept. The integration of real-time GMP manufacture and clinical testing minimises CMC investments and simplifies supply chains. By enhancing the design and speed of early phase clinical programmes, the pressure on R&D budgets is reduced and critical decisions are made sooner.

Join the discussion with our experts on the following topics:

Why attend?

Seminar dates:

How do I register? 

To register, please email stating your contact details and location preference or click the relevant seminar date for full details and to get in touch with our local Quotient Clinical representative.